Biblio

Export 11300 results:
Author Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Treatment Outcome
H. Florian, Meier, A., Gauthier, S., Lipschitz, S., Lin, Y., Tang, Q., Othman, A. A., Robieson, W. Z., and Gault, L. M., Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study., J Alzheimers Dis, vol. 51, no. 4, pp. 1237-47, 2016.
A. Homma, Atarashi, H., Kubota, N., Nakai, K., and Takase, T., Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial., J Alzheimers Dis, vol. 52, no. 1, pp. 345-57, 2016.
A. Sánchez, Maseda, A., M Marante-Moar, P., de Labra, C., Lorenzo-López, L., and Millán-Calenti, J. Carlos, Comparing the Effects of Multisensory Stimulation and Individualized Music Sessions on Elderly People with Severe Dementia: A Randomized Controlled Trial., J Alzheimers Dis, vol. 52, no. 1, pp. 303-15, 2016.
G. Cuberas-Borrós, Roca, I., Boada, M., Tárraga, L., Hernandez, I., Buendia, M., Rubio, L., Torres, G., Bittini, Á., Guzmán-de-Villoria, J. A., Pujadas, F., Torres, M., Núñez, L., Castell, J., and Páez, A., Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin., J Alzheimers Dis, vol. 61, no. 1, pp. 321-332, 2018.
J. Peter, Schumacher, L. V., Landerer, V., Abdulkadir, A., Kaller, C. P., Lahr, J., and Klöppel, S., Biological Factors Contributing to the Response to Cognitive Training in Mild Cognitive Impairment., J Alzheimers Dis, vol. 61, no. 1, pp. 333-345, 2018.
G. K. Wilcock, Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., Davis, C. S., Staff, R. T., Vuksanovic, V., Ahearn, T., Bracoud, L., Shamsi, K., Marek, K., Seibyl, J., Riedel, G., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial., J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
S. C. McEwen, Siddarth, P., Abedelsater, B., Kim, Y., Mui, W., Wu, P., Emerson, N. D., Lee, J., Greenberg, S., Shelton, T., Kaiser, S., Small, G. W., and Merrill, D. A., Simultaneous Aerobic Exercise and Memory Training Program in Older Adults with Subjective Memory Impairments., J Alzheimers Dis, vol. 62, no. 2, pp. 795-806, 2018.
L. Guzmán-Martínez, Calfío, C., Farías, G. A., Vilches, C., Prieto, R., and Maccioni, R. B., New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease., J Alzheimers Dis, vol. 82, no. s1, pp. S51-S63, 2021.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P., Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study., J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.
H. Sandison, Callan, N. G. L., Rao, R. V., Phipps, J., and Bradley, R., Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline., J Alzheimers Dis, vol. 94, no. 3, pp. 993-1004, 2023.
D. L. Alkon, Sun, M. - K., Tuchman, A. J., and Thompson, R. E., Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial., J Alzheimers Dis, vol. 96, no. 2, pp. 759-766, 2023.
Transfection
E. C. Pinnock, Jovanovic, K., Pinto, M. G., Ferreira, E., Dias, B. Da Costa, Penny, C., Knackmuss, S., Reusch, U., Little, M., Schatzl, H. M., and Weiss, S. F. T., LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 3, pp. 645-57, 2016.
Y. Shan, Wang, D. - D., Xu, Y. - X., Wang, C., Cao, L., Liu, Y. - S., and Zhu, C. - Q., Aging as a Precipitating Factor in Chronic Restraint Stress-Induced Tau Aggregation Pathology, and the Protective Effects of Rosmarinic Acid., J Alzheimers Dis, vol. 49, no. 3, pp. 829-44, 2016.
C. -cui Yang, Kuai, X. -xian, bin Gao, W. -, Yu, J. -chun, Wang, Q., Li, L., and Zhang, L., Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration., J Alzheimers Dis, vol. 51, no. 1, pp. 33-44, 2016.
A. K. Tripathi and Singh, N., Prion Protein-Hemin Interaction Upregulates Hemoglobin Synthesis: Implications for Cerebral Hemorrhage and Sporadic Creutzfeldt-Jakob Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 107-21, 2016.
J. Min Song, Sung, Y. Me, Nam, J. Han, Yoon, H., Chung, A., Moffat, E., Jung, M., Pak, D. T. S., Kim, J., and Hoe, H. - S., A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Increases Dendritic Spine Density via RasGRF1/ERK Pathway., J Alzheimers Dis, vol. 51, no. 2, pp. 591-604, 2016.
Y. Kim, Kim, C., Jang, H. Young, and Mook-Jung, I., Inhibition of Cholesterol Biosynthesis Reduces γ-Secretase Activity and Amyloid-β Generation., J Alzheimers Dis, vol. 51, no. 4, pp. 1057-68, 2016.
L. - S. Liu, Bai, X. - Q., Gao, Y., Wu, Q., Ren, Z., Li, Q., Pan, L. - H., He, N. - Y., Peng, J., and Tang, Z. - H., PCSK9 Promotes oxLDL-Induced PC12 Cell Apoptosis Through the Bcl-2/Bax-Caspase 9/3 Signaling Pathway., J Alzheimers Dis, vol. 57, no. 3, pp. 723-734, 2017.

Pages